Botanix Pharmaceuticals Limited

OTCPK:BXPH.F Stock Report

Market Cap: US$39.8m

Botanix Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:BXPH.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Apr 26SellUS$940,164Chester Asset Management Pty LtdCompany34,473,591US$0.027
10 Apr 26BuyUS$70,870Patricia WalkerIndividual1,666,667US$0.043
10 Apr 26BuyUS$70,870Stewart WasherIndividual1,666,667US$0.043
10 Apr 26BuyUS$70,870Henry BoschIndividual1,666,667US$0.043
10 Apr 26BuyUS$70,870Vincent IppolitoIndividual1,666,667US$0.043
10 Apr 26BuyUS$35,435Daniel SharpIndividual833,333US$0.043
26 Mar 26SellUS$598,204Chester Asset Management Pty LtdCompany16,000,000US$0.077
12 Mar 26BuyUS$227,381IOOF Investment Management LimitedCompany5,014,509US$0.058
12 Mar 26SellUS$1,760,589MLC Investments LimitedCompany27,699,640US$0.064
11 Mar 26SellUS$891,490IOOF Investment Management LimitedCompany5,525,288US$0.18
24 Feb 26BuyUS$828,606MLC Investments LimitedCompany18,103,301US$0.046
18 Nov 25BuyUS$2,032,098Copia Investment Partners LtdCompany20,600,000US$0.11
10 Nov 25SellUS$1,268,886MLC Investments LimitedCompany14,959,748US$0.085
07 Nov 25SellUS$1,013,692IOOF Investment Management LimitedCompany5,779,544US$0.18
03 Nov 25BuyUS$8,817IOOF Investment Management LimitedCompany100,000US$0.088
28 Oct 25SellUS$1,732,107IOOF Investment Management LimitedCompany10,977,635US$0.18
23 Oct 25BuyUS$1,226,771MLC Investments LimitedCompany6,347,313US$0.19
20 Oct 25BuyUS$538,377IOOF Investment Management LimitedCompany3,685,867US$0.20
26 Sep 25BuyUS$2,326,916Copia Investment Partners LtdCompany20,000,000US$0.21
23 Sep 25SellUS$1,470,541MLC Investments LimitedCompany14,313,367US$0.10

Insider Trading Volume

Insider Buying: BXPH.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BXPH.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders120,226,4864.4%
Institutions403,199,41614.7%
General Public2,210,886,89880.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 39.4%.

Top Shareholders

Top 17 shareholders own 19.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.22%
Copia Investment Partners Ltd
142,700,000US$2.1m0%0.75%
3.25%
Chester Asset Management Pty Ltd
88,850,154US$1.3m-3.29%2.57%
2.73%
Matthew Callahan
74,586,791US$1.1m0%no data
2.66%
MLC Investments Limited
72,725,542US$1.1m-11.7%0.17%
1.59%
UniSuper Management Pty Ltd
43,400,000US$631.8k0%no data
0.89%
Antares Capital Partners Limited
24,386,669US$355.0k0%3.31%
0.75%
Henry Bosch
20,503,369US$298.5k8.85%no data
0.61%
Vincent Ippolito
16,668,311US$242.7k11.1%no data
0.57%
Australian Super Pty Ltd
15,539,307US$226.2k0%no data
0.23%
OnePath Funds Management Limited
6,176,015US$89.9k0%0.23%
0.2%
Fideuram Asset Management (Ireland) DAC
5,346,048US$77.8k0%no data
0.14%
Stewart Washer
3,836,702US$55.9k-37.7%no data
0.11%
Daniel Sharp
2,964,646US$43.2k-43.5%no data
0.1%
IOOF Investment Management Limited
2,806,084US$40.8k-91.3%no data
0.061%
Patricia Walker
1,666,667US$24.3k0%no data
0.026%
Dimensional Fund Advisors LP
712,873US$10.4k-45.6%no data
0.02%
State Street Global Advisors, Inc.
556,724US$8.1k-0.51%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 00:59
End of Day Share Price 2026/07/01 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Botanix Pharmaceuticals Limited is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madeleine WilliamsCanaccord Genuity
Joseph PantginisH.C. Wainwright & Co.